Download PDF
Thromb Haemost 1999; 82(05): 1532-1537
DOI: 10.1055/s-0037-1614867
Rapid Communications
Schattauer GmbH

Lysophosphatidic Acid Activates Nuclear Factor Kappa B and Induces Proinflammatory Gene Expression in Endothelial Cells

Alois Palmetshofer
1   From the Institut für Klinische Biochemie und Pathobiochemie, Medizinische Kliniken Würzburg, Germany
,
Simon C. Robson
2   Department of Medicine, Beth Israel Deaconess Medical Center, Harvard University, Boston, USA
,
Volker Nehls
1   From the Institut für Klinische Biochemie und Pathobiochemie, Medizinische Kliniken Würzburg, Germany
› Author Affiliations
Further Information

Publication History

Received 22 October 1998

Accepted after resubmission 27 May 1999

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

Summary

The cellular phospholipid, lysophosphatidic acid (LPA), released by activated platelets and fibroblasts or, at high levels, from ovarian and cervical carcinomas is a powerful serum mitogen that may modulate several signaling pathways in endothelial cells (EC). Hence, LPA could function in a paracrine manner during EC-platelet interactions at sites of vascular injury.

Here, we demonstrate activation of the transcription factor nuclear factor kappa B (NF-κB) in EC following exposure to LPA. EC activation was further characterized by increased levels of mRNA transcripts encoding E-selectin, Intercellular Adhesion Molecule-1, Interleukin-8 and Monocyte Chemoattractant Protein-1. These effects were inhibited by preincubating EC either in the presence of mepacrine (to block phospholipase A2) or of pertussis toxin (to increase ADP-ribosylation of Gi proteins). No inhibition was observed in the presence of putative LPA receptor antagonists suramin or thrombospondin.

LPA induces a proinflammatory activation of endothelial cells that (i) involves Gi proteins; (ii) depends on phospholipase A2 activity; (iii) is associated with the activation of NF-κB and (iv) results in increased expression of proinflammatory genes. We propose that LPA release by activated platelets may directly modulate vascular inflammatory responses.

Abbreviations: EC, endothelial cells; LPA, lysophosphatidic acid; NF-κB, nuclear factor kappa B; PA, phosphatidic acid; IL-8, interleukin-8; MCP-1, monocyte chemoattractant protein-1, ICAM-1, intercellular adhesion molecule-1, vascular adhesion molecule-1; GAPDH, glycerol aldehyde phosphate dehydrogenase; MAPK, mitogen activated kinase, MEK, MAPK kinase, PAEC, porcine aortic EC.

Keywords

Lysophosphatidic acid - nuclear factor kappa B - transcription factor - inflammation - endothelial cells - platelets - gene expression
 

  • References

  • 1 Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur. Heart J 1993; 14 Suppl K 2-6.
    PubMedGoogle Scholar
  • 2 Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun 1993; 6: 237-49.
    CrossrefPubMedGoogle Scholar
  • 3 Taubman MB. Gene induction in vessel wall injury. Thromb Haemost 1993; 70: 180-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-44.
    CrossrefPubMedGoogle Scholar
  • 5 Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Ferran C, Bach FH. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation 1997; 63: 421-9.
    CrossrefPubMedGoogle Scholar
  • 6 Introna M, Mantovani A. Early activation signals in endothelial cells. Stimulation by cytokines. Arterioscler Thromb Vasc Biol 1997; 17: 423-8.
    CrossrefPubMedGoogle Scholar
  • 7 Mantovani A, Sozzani S, Vecchi A, Introna M, Allavena P. Cytokine activation of endothelial cells: new molecules for an old paradigm. Thromb Haemost 1997; 78: 406-14.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J Clin Invest 1997; 99: 763-72.
    CrossrefPubMedGoogle Scholar
  • 9 Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993; 291: 677-80.
    CrossrefPubMedGoogle Scholar
  • 10 Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF. Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 1997; 129: 208-16.
    CrossrefPubMedGoogle Scholar
  • 11 Moolenaar WH, van CE. Growth factor-like action of lysophosphatidic acid: mitogenic signalling mediated by G proteins. Ciba Found Symp 1990; 150: 99-106.
    PubMedGoogle Scholar
  • 12 Moolenaar WH. Lysophosphatidic acid signalling. Curr Opin Cell Biol 1995; 7: 203-10.
    CrossrefPubMedGoogle Scholar
  • 13 Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 1994; 267: C204-10.
    CrossrefPubMedGoogle Scholar
  • 14 Tigyi G, Dyer DL, Miledi R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci USA 1994; 91: 1908-12.
    CrossrefPubMedGoogle Scholar
  • 15 van Corven EJ, van Rijswijk A, Jalink K, van-der Bend RL, van Blitterswijk WJ, Moolenaar WH. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J 1992; 281: 163-9.
    CrossrefPubMedGoogle Scholar
  • 16 Xu Y, Shen Z, Wiper DW. et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719-23.
    CrossrefPubMedGoogle Scholar
  • 17 Westermann AM, Havik E, Postma FR. et al. Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 1998; 9: 437-42.
    CrossrefPubMedGoogle Scholar
  • 18 van der Bend R, Brunner J, Jalink K, van Corven EJ, Moolenaar WH, van Blitterswijk WJ. Identification of a putative membrane receptor for the bioactive phospholipid, lysophosphatidic acid. EMBO 1992; 11: 2495-501.
    CrossrefPubMedGoogle Scholar
  • 19 Moolenaar WH, Kranenburg O, Postma FR, Zondag GC. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 1997; 9: 168-73.
    CrossrefPubMedGoogle Scholar
  • 20 Kranenburg O, Verlaan I, Hordijk PL, Moolenaar WH. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO J 1997; 16: 3097-105.
    CrossrefPubMedGoogle Scholar
  • 21 von Albertini MA, Palmetshofer A, Kaczmarek E. et al. Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun 1998; 248: 822-9.
    CrossrefPubMedGoogle Scholar
  • 22 Anrather D, Millan MT, Palmetshofer A. et al. Thrombin activates nuclear factor-kappa B and potentiates endothelial cell activation by TNF. J Immunol 1997; 159: 5620-8.
    PubMedGoogle Scholar
  • 23 Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928-34.
    CrossrefPubMedGoogle Scholar
  • 24 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-$$$ phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
    PubMedGoogle Scholar
  • 25 Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. Transplantation 1998; 65: 971-8.
    CrossrefPubMedGoogle Scholar
  • 26 Stuhlmeier KM, Kao JJ, Bach FH. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappa B alpha/nuclear factor-kappa B (NF-kappa B) complex, thus suppressing the nuclear translocation of NF-kappa B. J Biol Chem 1997; 272: 24679-83.
    CrossrefPubMedGoogle Scholar
  • 27 Thommesen L, Sjursen W, Gasvik K. et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 1998; 161: 3421-30.
    PubMedGoogle Scholar
  • 28 Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 1995; 270: 12949-52.
    CrossrefPubMedGoogle Scholar
  • 29 Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC. Activation of the nuclear factor-kappa B by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997; 11: 463-75.
    CrossrefPubMedGoogle Scholar
  • 30 McLees A, Graham A, Malarkey K, Gould GW, Plevin R. Regulation of lysophosphatidic acid-stimulated tyrosine phosphorylation of mitogen-activated protein kinase by protein kinase C-$$$ and pertussis toxin-dependent pathways in the endothelial cell line EAhy 926. Biochem J 1995; 307: 743-8.
    CrossrefPubMedGoogle Scholar
  • 31 De Luca LG, Johnson DR, Whitley MZ, Collins T, Pober JS. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J Biol Chem 1994; 269: 19193-6.
    PubMedGoogle Scholar
  • 32 Pober JS, Slowik MR, De LL, Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-23.
    PubMedGoogle Scholar
  • 33 Stasek-JE J, Natarajan V, Garcia JG. Phosphatidic acid directly activates endothelial cell protein kinase C. Biochem Biophy Res Commun 1993; 191: 134-41.
    CrossrefPubMedGoogle Scholar
  • 34 Reiser CA, Lanz T, Hofmann F, Hofer G, Rupprecht HD, Goppelt-Struebe M. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and egr-1: a critical role for the mitogen-activated protein kinase p38 and for rho proteins. Biochem J 1998; 330: 1107-4.
    CrossrefPubMedGoogle Scholar